New England Civil Surgeons Webinar Series - Session Three

Monday, February 1, 2021, 12:00 AM - Sunday, August 1, 2021, 12:00 AM

This activity will provide civil surgeons with an overview of the technical instructions for mental health and substance abuse. 

Jointly provided by the Rutgers Global Tuberculosis Institute and the Massachusetts Department of Public Health

Funding for this course was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.

Release Date: February 1, 2021
Expiration Date: August 1, 2021
Estimated time to complete this activity as designed is 2.5 hours

Presenting Faculty
John Bernardo, MD
Tuberculosis Medical Officer
Massachusetts Department of Public Health

Laurie Courtney, MSN
Regional Immunization Nurse
Massachusetts Department of Public Health

Samantha Enokian
Policy Analyst
United States Citizenship and Immigration Services

Katherine Hsu, MD
Medical Director
Division of STD Prevention and HIV/AIDS Surveillance
Massachusetts Department of Public Health

Laura Rakuljic
Adjudications Officer
United States Citizenship and Immigration Services

Kim Skrobarcek, MD
Medical Officer
Centers for Disease Control and Prevention

1. Utilize best practices for screening for mental health and substance abuse disorders for applicants seeking to adjust their immigration status in the United States, as cited in the CDC technical instructions

In order to access the content, please click on the "Register" tab and complete your registration.  Once registered, please click on the "Online Content & Tests" tab and select "Launch Video" to view the on-demand webinar. 

How to Receive CE Credit: Participants should review the activity in its entirety and then complete the post-test, which is accessible on the "Online Content & Tests" tab. Upon completing this activity as designed, achieving a score of 100% on the post-test, and completing the evaluation, participants will be able to download their CE certificate. The CE certificate will also be emailed to you.

In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and the Massachusetts Department of Public Health. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Physicians: Rutgers Biomedical and Health Sciences designates this enduring material for a maximum of 2.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: This activity is awarded 2.5 contact hours. (60 minute CH) Nurses should claim only those contact hours actually spent participating in the activity.

Peer Review: In order to help ensure content objectivity, independence, and fair balance, and to ensure that the content is aligned with the interest of the public, Rutgers Biomedical and Health Sciences (RBHS) has resolved all potential and real conflicts of interest through content review by a non-conflicted, qualified reviewer. This activity was peer reviewed for relevance, accuracy of content and balance of presentation by Olivia Dupont, MPH.

Disclosure: In accordance with the disclosure policies of Rutgers and to conform with Joint Accreditation requirements and FDA guidelines, individuals in a position to control the content of this educational activity are required to disclose to the activity participants: (1) the existence of any relevant financial relationship with any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients, with the exemption of non-profit or government organizations and non-health care related companies, within the past 12 months; and (2) the identification of a commercial product/device that is unlabeled for use or an investigational use of a product/device that is not yet approved.

The following faculty and planning committee members have no relevant financial relationships to disclose:

Anita Khilall, MPH (Activity Director) - Program Director, Education & Training, Rutgers Global Tuberculosis Institute
John Bernardo, MD - Tuberculosis Medical Officer, Massachusetts Department of Public Health
Jennifer Cochran, MPH - Director, Division of Global Populations and Infectious Disease Prevention, Massachusetts Department of Public Health
Laurie Courtney, MSN - Regional Immunization Nurse, Massachusetts Department of Public Health
Olivia Dupont, MPH - Health Educator, Rutgers Global Tuberculosis Institute
Samantha Enokian - Policy Analyst, United States Citizenship and Immigration Services
Katherine Hsu, MD -  Medical Director, Division of STD Prevention and HIV/AIDS Surveillance, Massachusetts Department of Public Health
Patricia Iyer, MSN, RN - Director, Disease Investigation and Case Management, Massachusetts Department of Public Health
Laura Rakuljic - Adjudications Officer, United States Citizenship and Immigration Services
Kim Skrobarcek, MD - Medical Officer, Centers for Disease Control and Prevention
Laura Smock, MPH - Program Coordinator, Division of STD Prevention, Massachusetts Department of Public Health

RBHS Center for Continuing and Outreach Education Staff - Elizabeth Ward, MSJ, Executive Director, has no relevant financial relationships to disclose

This activity does not contain information about commercial products/devices that are unlabeled for use or investigational products not yet approved.

Content Disclaimer: The views expressed in this activity are those of the faculty. It should not be inferred or assumed that they are expressing the views of any manufacturer of pharmaceuticals or devices, Rutgers University or Massachusetts Department of Public Health.

It should be noted that the recommendations made herein with regard to the use of therapeutic agents, varying disease states, and assessments of risk, are based upon a combination of clinical trials, current guidelines, and the clinical practice experience of the participating presenters. The drug selection and dosage information presented in this activity are believed to be accurate. However, participants are urged to consult all available data on products or procedures before using them in clinical practice.

Copyright © 2020-21. Rutgers Biomedical and Health Sciences and Massachusetts Department of Public Health. All rights reserved including translation into other languages. No part of this activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, recording or any information storage and retrieval systems, without written permission from Rutgers.

Questions: Please direct content, CE-related or technical questions or concerns to Rutgers Center for Continuing and Outreach Education (CCOE) by email at [email protected].

To review CCOE's privacy policy, please click here.

AMA PRA Category 1 Credits™ (2.50 hours), ANCC Contact Hours (2.50 hours), Non-Physician Attendance (2.50 hours)

No faculty are available for this activity at this time.